New data shows that NIH research grants generated $94.15B in economic activity, stemming from $36.58B in grant funding, highlighting how despite enduring funding delays and policy uncertainty in the 2025 fiscal year, the NIH continues to deliver remarkable economic and scientific value.

In a report by United for Medical Research, these numbers translate into roughly $2.57 in economic impact for every $1 invested – serving as a powerful reminder that federal funding is both a scientific as well as an economic investment. The year before, the NIH awarded $36.94 billion in grants that generated $2.56 for every dollar invested, equating to a total impact of $94.58 billion.

However, due to government shut down and leadership turnover, the NIH for FY25 was 30% behind schedule in awarding research money. As a result, the NIH deployed a new budget mechanism called multi-year funding, delivering the full value of specific grants upfront rather than annually, allowing the NIH to spend its full budget on fewer grants.

For researchers and biotech innovators, these trends underscore an important reality: competition for federal funding is intensifying, even as the economic and societal returns remain undeniable.

For us at FreeMind, we know that strategic planning, early positioning, and a diversified funding strategy are becoming increasingly important for organizations seeking to secure non-dilutive funding and accelerate scientific innovation.

The data is clear: when biomedical research is funded, the returns extend far beyond the lab!

Source: Fierce Biotech